Nebert D W, Petersen D D, Puga A
Department of Environmental Health, University of Cincinnati Medical Center, OH 45267-0056.
Pharmacogenetics. 1991 Nov;1(2):68-78. doi: 10.1097/00008571-199111000-00003.
The polymorphism of mammalian aromatic hydrocarbon (Ah) responsiveness appears to be correlated with genetic differences in risk of bronchogenic carcinoma caused by cigarette smoking. The human polymorphism has been uncovered, largely as the result of corresponding genetic differences characterized first in the mouse. The murine Ah locus has been defined as the gene encoding the aromatic hydrocarbon-responsive (Ah) receptor, responsible for the inducibility of a battery of at least six genes, two of which encode P450 enzymes. The high-affinity receptor and, hence, more highly induced levels of P450, can result in greater concentrations of polycyclic aromatic reactive intermediates that form DNA adducts and, ultimately, mutation fixation (tumour initiation). The Ah receptor is also likely to participate in growth and differentiation signal transduction pathways (tumour promotion). Positive and negative control regions flanking the murine Cyp 1a-1 and human CYP1A1 (cytochrome P(1)450) genes have been identified. A DNA motif approximately 1 kb upstream of the transcription start site appears to affect the translatability of the CYP1A1 mRNA and activity of the enzyme. Expression of the CYP1A1 or CYP1A2 enzyme in mouse hepatoma Hepa-1 cells lacking endogenous CYP1A1 activity represses constitutive transcription of not only the endogenous Cyp1a-1 gene but other genes in the dioxin-inducible [Ah] battery. Human polymorphisms involving a Msp I site 450 bp downstream from the last CYP1A1 exon have been described in Japan, the Eastern Mediterranean, Norway and the USA. The '1.9 allele' is associated with an increased incidence of Kreyberg Type I bronchogenic carcinomas in Japan and has recently been correlated with a valine-to-isoleucine substitution at position 462 in the haeme-binding region. This allele is about 3 times more frequent in Japan than in Caucasians of Norway and the USA, in which no correlation has been found between this allele and lung cancer. More work is needed to clarify these findings. Isolation and sequencing of the human Ah receptor cDNA, and the subsequent screening of populations for polymorphisms, hold great promise for predicting interindividual risk of cancer caused by smoking and other environmental pollutants.
哺乳动物对芳香烃(Ah)反应的多态性似乎与吸烟引起的支气管源性癌风险的遗传差异相关。人类的多态性已被发现,这主要是对小鼠中首先表征的相应遗传差异研究的结果。小鼠的Ah位点已被定义为编码芳香烃反应性(Ah)受体的基因,该受体负责诱导至少六种基因,其中两种基因编码P450酶。高亲和力受体以及更高水平诱导的P450,可导致更高浓度的多环芳烃反应性中间体,这些中间体形成DNA加合物,并最终导致突变固定(肿瘤起始)。Ah受体也可能参与生长和分化信号转导途径(肿瘤促进)。已确定了小鼠Cyp 1a-1和人类CYP1A1(细胞色素P(1)450)基因两侧的正调控区和负调控区。转录起始位点上游约1 kb处的一个DNA基序似乎会影响CYP1A1 mRNA的可翻译性和该酶的活性。在缺乏内源性CYP1A1活性的小鼠肝癌Hepa-1细胞中,CYP1A1或CYP1A2酶的表达不仅会抑制内源性Cyp1a-1基因的组成型转录,还会抑制二恶英诱导的[Ah]基因簇中其他基因的转录。在日本、东地中海地区、挪威和美国,已描述了涉及CYP1A1最后一个外显子下游450 bp处Msp I位点的人类多态性。“1.9等位基因”与日本克雷伯格I型支气管源性癌的发病率增加有关,最近还与血红素结合区域第462位的缬氨酸到异亮氨酸替代相关。该等位基因在日本的频率比挪威和美国的白种人高约3倍,在后者中未发现该等位基因与肺癌之间存在相关性。需要开展更多工作来阐明这些发现。分离和测序人类Ah受体cDNA,并随后对人群进行多态性筛查,对于预测吸烟和其他环境污染物导致的个体间癌症风险具有很大前景。